This inventor holds 1 USPTO granted patent. Top assignee: Greenlight Biosciences, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Kelsey A Haugh: Innovator in Nucleic Acid Therapeutics
Introduction
Kelsey A Haugh is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of genetic therapies, particularly through her innovative work in nucleic acid therapeutics. Her research focuses on developing solutions for genetic disorders, showcasing her commitment to advancing medical science.
Latest Patents
Kelsey A Haugh holds a patent for "Nucleic acid therapeutics for genetic disorders." This patent involves compositions based on retroviruses, such as lentiviruses, which comprise nucleic acid molecules encoding retroviral Pol polyprotein components. The invention aims to deliver transgenes to target cells, either ex vivo or in vivo, to treat various genetic disorders. The compositions are designed to stably express transgenes that can have a biological effect, addressing conditions like sickle cell disease, beta-thalassemia, and cystic fibrosis, among others. Kelsey has 1 patent to her name.
Career Highlights
Kelsey A Haugh is currently associated with Greenlight Biosciences, Inc., where she continues her groundbreaking work in genetic therapies. Her role at the company allows her to collaborate with other experts in the field and contribute to innovative solutions for complex health issues.
Collaborations
Kelsey has worked alongside notable colleagues, including Christian Matranga and James Robbins Abshire. These collaborations have further enriched her research and development efforts in nucleic acid therapeutics.
Conclusion
Kelsey A Haugh is a trailblazer in the field of genetic therapies, with her innovative patent addressing critical health challenges. Her work at Greenlight Biosciences, Inc. exemplifies her dedication to improving patient outcomes through scientific advancements.